Litigation Details for Cephalon, Inc. v. Slayback Pharma Limited Liability Company (D. Del. 2017)
✉ Email this page to a colleague
Cephalon, Inc. v. Slayback Pharma Limited Liability Company (D. Del. 2017)
| Docket | ⤷ Subscribe | Date Filed | 2017-08-16 |
| Court | District Court, D. Delaware | Date Terminated | 2020-07-06 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Parties | APOTEX CORP. | ||
| Patents | 10,010,533; 10,052,385; 8,609,707; 8,791,270; 9,000,021; 9,034,908; 9,144,568; 9,265,831; 9,572,796; 9,572,797; 9,572,887; 9,579,384; 9,597,397; 9,597,398; 9,597,399 | ||
| Attorneys | Anjali D. Deshmukh | ||
| Firms | Shaw Keller LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Cephalon, Inc. v. Slayback Pharma Limited Liability Company
The small molecule drugs covered by the patents cited in this case are ⤷ Subscribe , ⤷ Subscribe , and ⤷ Subscribe .
Details for Cephalon, Inc. v. Slayback Pharma Limited Liability Company (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-10-19 | 164 | Status Report | Book patents have issued during the course of the current litigation. U.S. Patent No. 10,010,533 (“the…infringes the ’707 patent, the ’831 patent, the ’796 patent, the ’797 patent, and the ’533 patent by seeking …assignee of U.S. Patent Nos. 8,609,707 (the “’707 patent”), 9,265,831 (the “’831 patent”), 9,572,796 (the…9,034,908 (the “’908 patent”), 9,144,568 (the “’568 patent”), 9,572,887 (the “’887 patent”), 9,597,397 (the…(the “’397 patent”), 9,597,398 (the “’398 patent”), 9,597,399 (the “’399 patent”), 9,000,021 (the “’021 | External link to document |
| 2018-12-04 | 207 | any of the three disputed claims of U.S. Patent No. 8,791,270 that were identified in the parties’ Joint…any of the three disputed claims of U.S. Patent No. 8,791,270 that were identified in the parties’ Joint…to the same issue regarding one or more of the patents-in- suit shall count as one interrogatory. To the… Joint Claim Construction Brief as to the ’270 Patent January 18, 2019 (If Necessary) Final Invalidity…2019 Claim Construction Hearing as to the °270 Patent February 5, 2019 (If Necessary) Opening Expert | External link to document | |
| 2019-09-05 | 315 | Redacted Document | the “’831 patent”), 9,572,796 (the “’796 patent”), 9,572,797 (the “’797 patent”), 10,010,533 (the “’533…following patents: U.S. Patent Nos. 8,791,270 (the “’270 patent”), 8,609,707 (the “’707 patent”), 9,265,831…533 patent”), 9,034,908 (the “’908 patent”), 9,144,568 (the “’568 patent”), 9,572,887 (the “’887 patent…,397 (the “’397 patent”), 9,597,398 (the “’398 patent”), 9,597,399 (the “’399 patent”), 10,052,385 (the…(the “’385 patent”), 9,000,021 (the “’021 patent”), and 9,579,384 (the “’384 patent”). 2. | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
